Avalo Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 08/15/2022 | 47.58 M | $23.79 M | 0.00% | 42.17% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 08/15/2022 | 6.71 M | $3.36 M | -2.03% | 5.95% |
POINT72 ASSET MANAGEMENT, L.P. | 08/15/2022 | 6.01 M | $3.00 M | 0.00% | 5.33% |
VANGUARD GROUP INC | 08/12/2022 | 3.07 M | $1.54 M | -9.27% | 2.72% |
BLACKROCK INC. | 08/12/2022 | 1.24 M | $622.00 K | -66.97% | 1.10% |
MILLENNIUM MANAGEMENT LLC | 08/15/2022 | 1.01 M | $506.00 K | 100.00% | 0.90% |
GEODE CAPITAL MANAGEMENT, LLC | 08/12/2022 | 846.39 K | $423.00 K | -37.90% | 0.75% |
GOLDMAN SACHS GROUP INC | 05/14/2024 | 649.65 K | $324.00 K | 23.77% | 0.58% |
OPALEYE MANAGEMENT INC. | 08/15/2022 | 450.00 K | $225.00 K | -69.06% | 0.40% |
RENAISSANCE TECHNOLOGIES LLC | 08/12/2022 | 340.03 K | $170.00 K | -7.40% | 0.30% |
STATE STREET CORP | 08/15/2022 | 307.74 K | $154.00 K | -68.49% | 0.27% |
ERGOTELES LLC | 08/12/2022 | 284.57 K | $142.00 K | 100.00% | 0.25% |
D. E. SHAW & CO., INC. | 08/15/2022 | 207.68 K | $104.00 K | -35.17% | 0.18% |
NORTHERN TRUST CORP | 08/12/2022 | 116.46 K | $58.00 K | -78.22% | 0.10% |
CITADEL ADVISORS LLC | 08/15/2022 | 88.97 K | $44.00 K | 205.13% | 0.08% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/15/2022 | 56.95 K | $29.00 K | -57.93% | 0.05% |
BANK OF NEW YORK MELLON CORP | 08/15/2022 | 48.31 K | $24.00 K | -70.07% | 0.04% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/15/2022 | 44.31 K | $22.00 K | 100.00% | 0.04% |
MORGAN STANLEY | 10/27/2022 | 40.45 K | $20.00 K | -46.29% | 0.04% |
MINOT WEALTH MANAGEMENT LLC | 07/12/2022 | 34.65 K | $17.00 K | 0.00% | 0.03% |
STIFEL FINANCIAL CORP | 08/15/2022 | 30.00 K | $15.00 K | 20.00% | 0.03% |
Y-INTERCEPT (HONG KONG) LTD | 08/08/2022 | 26.08 K | $13.00 K | 100.00% | 0.02% |
ORION PORTFOLIO SOLUTIONS, LLC | 07/14/2022 | 25.48 K | $13.00 K | 100.00% | 0.02% |
CREATIVE PLANNING | 08/15/2022 | 20.37 K | $10.00 K | 0.00% | 0.02% |
CIBC PRIVATE WEALTH GROUP, LLC | 08/03/2022 | 20.00 K | $10.00 K | 0.00% | 0.02% |
MEEDER ASSET MANAGEMENT INC | 08/08/2022 | 18.08 K | $9.00 K | 3.79% | 0.02% |
BALYASNY ASSET MANAGEMENT L.P. | 08/15/2022 | 16.00 K | $8.00 K | 100.00% | 0.01% |
VICTORY CAPITAL MANAGEMENT INC | 08/01/2022 | 15.37 K | $8.00 K | -0.26% | 0.01% |
AVANTAX PLANNING PARTNERS, INC. | 07/18/2022 | 12.66 K | $6.00 K | 100.00% | 0.01% |
MOODY LYNN & LIEBERSON, LLC | 07/28/2022 | 10.00 K | $5.00 K | 0.00% | 0.01% |
MAYFLOWER FINANCIAL ADVISORS, LLC | 07/15/2022 | 10.00 K | $5.00 K | 0.00% | 0.01% |
UBS GROUP AG | 08/10/2022 | 8.53 K | $4.00 K | -61.92% | 0.01% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 08/15/2022 | 5.72 K | $3.00 K | 51.91% | 0.01% |
LEGAL & GENERAL GROUP PLC | 08/22/2022 | 4.22 K | $2.00 K | -24.37% | 0.00% |
ROYAL BANK OF CANADA | 08/15/2022 | 3.96 K | $2.00 K | -0.10% | 0.00% |
TCI WEALTH ADVISORS, INC. | 07/19/2022 | 3.01 K | $2.00 K | 0.00% | 0.00% |
WASHINGTON TRUST CO | 07/25/2022 | 3.00 K | $2.00 K | 0.00% | 0.00% |
CITIGROUP INC | 08/10/2022 | 2.32 K | $1.00 K | 2.43% | 0.00% |
GROUP ONE TRADING, L.P. | 08/11/2022 | 2.20 K | $1.00 K | -56.41% | 0.00% |
JPMORGAN CHASE & CO | 08/11/2022 | 1.85 K | $1.00 K | -93.68% | 0.00% |
POINT72 HONG KONG LTD | 08/15/2022 | 1.77 K | $1.00 K | -47.29% | 0.00% |
FMR LLC | 08/12/2022 | 1.22 K | $1.00 K | 100.00% | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 08/16/2022 | 750 | $0 | 100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 08/10/2022 | 500 | $0 | 0.00% | 0.00% |
SIMPLEX TRADING, LLC | 08/03/2022 | 400 | $0 | 100.00% | 0.00% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 07/15/2022 | 129 | $0 | 0.00% | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 08/12/2022 | 54 | $0 | 0.00% | 0.00% |
CREDIT SUISSE AG/ | 08/12/2022 | 33 | $0 | 100.00% | 0.00% |
KISTLER-TIFFANY COMPANIES, LLC | 08/08/2022 | 23 | $0 | 0.00% | 0.00% |
PARALLEL ADVISORS, LLC | 08/01/2022 | 6 | $0 | 0.00% | 0.00% |
Avalo Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Avalo Therapeutics, Inc.. The most heavily invested institutionals were:
Minot Wealth Management LLC: 34,645
BREWIN DOLPHIN LTD: 0
Amalgamated Financial Corp.: 9,807
Asymmetry Capital Management, L.P.: 0
61.50% of Avalo Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.45 K shares in the last 24 months. This purchase volume represents approximately $177.81 K in transactions.